BIOCEPT INC - 09072V105
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2014
· Q1 2014
Value (USD)
Total reported value ($000)
$2.68M
QoQ value delta ($000)
-$597K
(-18.22%)
Implied price effect (QoQ)
-10.49%
Shares
Total shares
407,698
QoQ shares delta
-38,516
(-8.63%)
Total shares held by funds (by quarter)
Top holders (Q2 2014)
Top 25 only
Full list
Partial Q2 2014 data: 4 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 923 | 153,400 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 657 | 89,450 | 0.46% |
| Verition Fund Management LLC | 591 | 80,483 | 0.09% |
| LMR Partners LLP | 264 | 43,852 | 0.02% |
| VANGUARD GROUP INC | 177 | 29,465 | 0.0% |
| Camelot Portfolios, LLC | 60 | 10,000 | 0.04% |
| UBS AG | 5 | 707 | 0.0% |
| MORGAN STANLEY | 2 | 208 | 0.0% |
| WELLS FARGO & COMPANY/MN | 1 | 125 | 0.0% |
| CITIGROUP INC | 0 | 8 | 0.0% |